NA Proactive news snapshot: Mawson Gold, CytoDyn, Benchmark Metals, Tetra Bio-Pharma ...

Mawson Gold Ltd (TSE:MAW) (OTCPINK:MWSNF) (FRA:MXR) told investors it had kicked off drilling at the Mount Isa block in Queensland, Australia and applied to increase its large ground position in the area. The Queensland government has provided a grant of A$200,000, which will fully fund one 800 metres (m) long drill hole to test a large undrilled gravity anomaly, called the F11 target. F11 lies laterally from the so-called Cloncurry fault, a significant regional structure, which in itself is near the Cannington silver-lead mine owned by South32 Ltd - the ninth-largest silver producer in the world with 12.3 million ounces (Moz) produced last year. CytoDyn Inc.(OTCQB:CYDY), a biotechnology company developing leronlimab (PRO 140) for multiple indications, revealed on Tuesday that the Data Safety Monitoring Committee (DSMC) had issued a positive interim analysis of leronlimab in the Phase 2b/3 registrational trial in patients with severe-to-critical coronavirus (COVID-19). The Vancouver, Washington-based company said the interim analysis was performed on data from the first 195 (50%) of 390 planned patients. Benchmark Metals Inc (CVE:BNCH) (OTCQX:BNCHF) continues to report good drill results from the flagship Lawyers project in British Columbia, which show the potential to expand the resource. The latest assays hail from the AGB zone of the project, where broad zones, including 41.94 metres (m) of 1.49 grams per tonne (g/t) gold and 106.84 g/t silver or 2.82 g/t gold equivalent (AuEq), were encountered. So far this year, 61 holes for 11,863 metres have been completed at AGB and gold-silver mineralization has been expanded to the west and shows a more than 600-metre strike length. Tetra Bio-Pharma Inc (TSE:TBP) (OTCQB:TBPMF) (FRA:JAM1), a leader in cannabinoid-derived drug discovery, shared the promising results of an experimental study with its investigational new drug ARDS-003 in a model of lung injury. The Canadian biopharmaceutical company said it has completed pre-clinical studies demonstrating the anti-inflammatory effect of ARDS-003, in an animal model of lung injury known as "induced pulmonary fibrosis" (IPF). This occurs when lung tissue is scarred, often as a result of extreme or prolonged inflammation, and results in a stiffening of lung tissue that may lead to respiratory problems and, in extreme cases, respiratory failure. While human conditions associated with lung injury may be caused by autoimmune disorders or viral infections, application of inflammatory agents such as bleomycin has been shown to induce similar effects in animal models. The company said its potential coronavirus therapy ARDS-003 reduced the levels of key inflammatory cytokine markers. African Gold Group Inc (CVE:AGG) revealed new drill results on Tuesday that confirmed gold mineralization along the Gosso shear zone at the Kobada gold project in Mali. Diamond drilling at Gosso showed a highly mineralized gold ore body with similar characteristics to the parallel Kobada shear zone, which boasts a total resource of 2.3 million ounces over a four-kilometre strike length. Revive Therapeutics Ltd (CSE:RVV) (OTCMKTS:RVVTF) (FRA:31R) has signed a supply agreement with Havn Life Sciences Inc. (CSE:HAVN) (FRA:5NP) to source naturally derived psychedelic compounds such as psilocybin for use in future investigational new drug (IND) enabling studies and clinical trials under US Food and Drug Administration guidelines. "We are excited about our strategic partnership with Havn Life as one of our suppliers of psychoactive compounds that we intend to develop and commercialize using our established tannin-chitosan based proprietary oral-thin film delivery system, for the pharmaceutical and wellness markets,” said Revive CEO Michael Frank in a statement Tuesday. “We are developing unique products with both synthetic and naturally-derived psilocybin and building relationships with companies and institutions that support our objectives in the psychedelic space including our established relationship with the University of Wisconsin-Madison in the research and clinical development of our novel Psilocybin oral-thin film product and the Phase 1 clinical study using psilocybin in the treatment of methamphetamine use disorder.” HealthLynked Corp (OTCQB:HLYK) announced on Tuesday that through a cash-and-stock deal, it has acquired MedOfficeDirect LLC (MOD), a Naples, Florida-based virtual distributor of discounted medical supplies to both consumers and medical practices. The acquisition, costing up to $6 million, includes $2.7 million of HealthLynked stock issued at the closing of the deal, $0.7 million in cash, and up to $2.6 million of additional HealthLynked common stock, based on MOD achieving specific annual revenue milestones for the next four years, said the company. According to the company, the new acquisition is expected to contribute around $1.5 million of revenue in year one, increasing HealthLynked's consolidated revenues by some 25%. Exro Technologies Inc. (CVE:EXRO) (OTCQB:EXROF) has announced that it is opening the doors to the newly established Calgary Innovation Center, a major milestone for Exro in its path to delivering commercial products. The leading technology company, which has developed a new class of power electronics for electric motors and powertrains, said the new facility will allow in-house design, testing, and assembly of manufactured products to enhance the performance of electric motors and powertrains. The test equipment will feature small and large test bays that will demonstrate the patented technology in relevant environments and accelerate prototypes in operating applications, it added. Media Central Corporation Inc (CSE:FLYY) (FRA:3AT) has expanded its existing partnership with iMD Health Global (iMD) to provide readers of NOW Magazine, the Georgia Straight and Canncentral.com with up-to-date health information. New co-branded spaces in partnership with iMD appeared in NOW starting October 8 and will soon be implemented on the Straight and Canncentral platforms, the company said. These areas are designed to give health brands the opportunity to offer expert insight through branded content.  NexTech AR Solutions Corp (OTCQB:NEXCF) (CSE:NTAR) (FRA:N29) announced Tuesday that its InfernoAR platform has been selected by Enterprise Florida Inc for the first-ever virtual Florida International Trade Expo, to be held on March 16-18, 2021. Enterprise Florida is a public-private partnership between business and government leaders and is the principal economic development organization for the state. The contract with NexTech has an initial value of $200,000 over a span of 12 months. Viscount Mining Corp (CVE:VML) (OTCQB:VLMGF) (FRA:7VM) told investors it had increased its ground at the Cherry Creek project in eastern White Pine County, Nevada, by staking a further 24 claims in the southeast section. The Cherry Creek asset comprises 293 unpatented and patented claims as well as mill rights and spans over 2,442 hectares. It includes more than 20 past producing mines and the new claims are next to an area of prolific historic gold and silver mining, said the company. Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) has closed on the $1,018,000 purchase of cannabis-processing equipment and leasehold improvements from CMAX Technologies Inc in Ontario. In a statement Tuesday, Canntab said the purchase price was based upon third-party valuations it had ordered. The purchase price was satisfied through the issuance of 1,996,078 common shares of the company at $0.51 each. A deposit of 200,000 shares was paid to CMAX shortly after the execution of the asset purchase agreement. Medallion Resources Ltd (CVE:MDL) (OTCQB:MLLOF) has revealed that its shares are now changing hands on the OTCQB venture market in New York, increasing the group's access to US-based retail and institutional investors. It comes after the OTC Markets approved the move, which, the firm said, aligns well with Medallion’s focus on production of rare-earth elements (REE) within North America. "While the TSX Venture Exchange remains Medallion’s primary capital market, our leading position in the REE industry, and the importance of REEs to U.S. industry and defense makes the OTCQB Venture Market a natural fit,” said the group's CEO Mark Saxon in a statement. American Manganese Inc. (CVE:AMY) (OTCPINK:AMYZF) (FRA:2AM) has announced that the company will be extending the exercise period of a total of 1,378,666 share purchase warrants, all of which are exercisable at $0.25 per share. The warrants were issued under a private placement which closed over two tranches in 2017, and the expiry dates for the outstanding warrants had been extended previously by one year. The company proposes to extend the expiry dates for all warrants by another year, and accordingly, the new expiry dates for the warrants are as follows: Tranche 1: For warrants issued on November 1, 2017, the new expiration date of those warrants will be November 1, 2021; Tranche 2: For warrants issued on December 1, 2017, the new expiration date of those warrants will be December 1, 2021. All other terms and conditions of the warrants remain unchanged. The warrant extension is subject to acceptance by the TSX Venture Exchange. Metalla Royalty and Streaming Ltd (CVE:MTA) said the TSX Venture Exchange has accepted for filing documentation relating to a sale and purchase agreement dated September 17, 2020, between it and vendor Morgan Stanley Capital Group Inc., whereby the company has acquired an existing 27.5% price participation royalty interest on Karora Resources Inc.'s operating Higginsville gold mine, located in Western Australia. Under the terms of the agreement, the US$6.5 million purchase price was satisfied via the issuance of 828,331 common shares at a deemed value of US$7.847 per share. KULR Technology Group, Inc. (OTCQB:KULR) has said its CEO, Michael Mo, has been invited to present at 'Building the Electric Vehicle Future' Webinar, presented by Maxim Group LLC and M-Vest, on Thursday October 22, 2020, at 11.00am. Eastern time (8.00am Pacific time). Mo will participate in a panel discussion led by Maxim senior research analyst Tate Sullivan, along with other important voices in the electric vehicle industry. Daily developments in the electric vehicle industry suggest many companies may benefit from long-term adoption. EV executives will discuss how their companies can benefit from long-term growth in this industry. To access the conference, investors can click here: https://m-vest.com/insights/marketpulse/rsvp-building-the-electric-vehicle-future?utm_source=newsletter&utm_medium=network&utm_campaign=electric-vehicle-webinar&utm_term=kurl VolitionRx Limited (NYSEAMERICAN:VNRX), a multi-national epigenetics company developing simple, easy to use, cost-effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, said it hosted a virtual capital markets day event on Tuesday, October 20, 2020, which started at 8.00am Eastern Time. Cameron Reynolds, the group's president and chief executive officer hosted the live-streamed event along with other members of the executive management team. The presentation will focus on new data, and the launch and commercial roll-out of the company's first product, the Nu.Q Vet Cancer Screening Test, which is on target for a launch this year, and will also provide an update on recent developments and Volition's activities, including new and ongoing clinical trials. A recording of the event will be posted to the Volition website on Wednesday, October 21. CytoDyn Inc. said that Nader Pourhassan, its president and chief executive officer, Scott Kelly, its chairman, chief medical officer and head of Business Development, and Jacob Lalezari, its senior science advisor, will host an investment community webcast on Tuesday, October 20, 2020, at a new time of 2.00pm PT / 5.00pm ET, which is one hour later than the previously announced time. The webcast can also be accessed via the following link: https://78449.themediaframe.com/dataconf/productusers/cydy/mediaframe/41443/indexl.html. The replay will be available approximately 60 minutes after the conclusion of the webcast and can be accessed via the above link until November 20, 2020. OTC Markets Group Inc. (OTCQX:OTCM), the operator of financial markets for 11,000 US and global securities, has announced that GT Gold Corp. (CVE:GTT) (OTCQX:GTGDF), a company focused on exploring for base and precious metals in British Columbia's Golden Triangle, has qualified to trade on the OTCQX Best Market and has today upgraded from the OTC Pink market. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information available in the US. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws. "We are very pleased to be upgrading to the OTCQX Market," said Paul Harbidge, president and chief executive officer of GT Gold Corp. "We look forward to expanding our disclosure and visibility to connect with new investors across the US and to share GT Gold's exciting new gold and copper discoveries in Canada," he added. Water Tower Research has issued three new analyst notes by equity research veteran Dr John Roy, who recently joined the firm as Managing Director – IT Hardware. The notes are on Infinera (NASDAQ: INFN) https://wp-wtr-2020.s3.eu-west-2.amazonaws.com/media/2020/10/18162727/INFN_IOC_Brief_v5-UpChrt.pdf; Extreme Networks (NASDAQ: EXTR)  https://wp-wtr-2020.s3.eu-west-2.amazonaws.com/media/2020/10/18162725/EXTR_IOC_Brief_v5-UpChrt.pdf; and Cisco Systems (NASDAQ: CSCO) https://wp-wtr-2020.s3.eu-west-2.amazonaws.com/media/2020/10/18162723/CSCO_IOC_Brief_v6-UpChrt.pdf